Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 450 of 463 entries
View as:

Study on The Value of Endobronchial Ultrasound Elastography in The Diagnosis of Thoracic Lesions

Phase: N/A Priority: Normal
NCT ID: NCT02755506 Org: User:
Start: 10/31/15 End: 10/31/16 Due: 10/31/17

A Study Evaluating UCART019 in Patients With Relapsed or Refractory CD19+ Leukemia and Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT03166878 Org: User:
Start: 06/30/17 End: 05/31/22 Due: 05/31/23

The Application of Soluble Triggering Receptor Expressed on Myeloid Cells-1 in Sepsis & Relevant Acute Kidney Injuries

Phase: N/A Priority: Normal
NCT ID: NCT01333657 Org: User:
Start: 05/31/10 End: 04/30/11 Due: 04/30/12

efficAcy and Safety of Home-baSed Cardiac rehabIlitation in ChineSe Revascularized patienTs

Phase: N/A Priority: Normal
NCT ID: NCT03102346 Org: User:
Start: 11/09/17 End: 12/31/21 Due: 12/31/22

Ruxolitinib and Chidamide for Acute T Cell Lymphoblast Leukemia/ Lymphoblastic Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT05075681 Org: User:
Start: 11/01/21 End: 06/01/25 Due: 06/01/26

Safety and Efficiency of γδ T Cell Against Hematological Malignancies After Allo-HSCT

Phase: N/A Priority: Normal
NCT ID: NCT04764513 Org: User:
Start: 09/12/21 End: 04/30/25 Due: 04/30/26

Prospective Multicenter Study on Clinical Application of Sonozoid in Thyroid Tumor

Phase: N/A Priority: Normal
NCT ID: NCT04574258 Org: User:
Start: 10/01/20 End: 08/01/21 Due: 08/01/22

Azacytidine, Bendamustine, Piamprizumab in Refractory/Relapsed B-cell Non-Hodgkin's Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT04897477 Org: User:
Start: 04/22/21 End: 04/23/23 Due: 04/23/24

An Open-label, Phase I/II Study of PLENA Regimen in Patients With Unresectable Pancreatic Cancer or BTC

Phase: N/A Priority: Normal
NCT ID: NCT05327582 Org: User:
Start: 04/12/22 End: 04/30/24 Due: 04/30/25

Radiofrequency Ablation of Malignant Pulmonary Nodules

Phase: N/A Priority: Normal
NCT ID: NCT02629978 Org: User:
Start: 10/31/15 End: 10/31/20 Due: 10/31/21

Study on Application of Simulated Training in Ultrasound Guided Transversus Abdominis Plane Block

Phase: N/A Priority: Normal
NCT ID: NCT04388423 Org: User:
Start: 05/15/20 End: 01/01/21 Due: 01/01/22

Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL

Phase: N/A Priority: Normal
NCT ID: NCT06321289 Org: User:
Start: 03/20/24 End: 03/20/27 Due: 03/20/28

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B-ALL

Phase: N/A Priority: Normal
NCT ID: NCT06481735 Org: User:
Start: 02/15/25 End: 02/15/28 Due: 02/15/29

TCR Reserved and Power3 (SPPL3) Gene Knock-out Allogeneic CD19-targeting CAR-T Cell Therapy in r/r B Cell Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06323525 Org: User:
Start: 04/17/24 End: 04/25/27 Due: 04/25/28

Effectiveness of Autologous Platelet-rich Plasma on Knee Cartilage Injury

Phase: N/A Priority: Normal
NCT ID: NCT03024801 Org: User:
Start: 02/29/12 End: 05/31/16 Due: 05/31/17

Decitabine Combining Modified CAG Followed by HLA Haploidentical Peripheral Blood Mononuclear Cells Infusion for Elderly Patients With Acute Myeloid Leukemia(AML）

Phase: N/A Priority: Normal
NCT ID: NCT01690507 Org: User:
Start: 11/30/12 End: 01/31/16 Due: 01/31/17

Ultrasound-guided Thermal Ablation for Benign Thyroid Nodules

Phase: N/A Priority: Normal
NCT ID: NCT06729762 Org: User:
Start: 12/09/24 End: 12/31/30 Due: 12/31/31

A Clinical Study of Adebrelimab Combined With Apatinib and Paclitaxel in Patients With Advanced Gastric Cancer.

Phase: N/A Priority: Normal
NCT ID: NCT06339216 Org: User:
Start: 03/20/24 End: 11/30/26 Due: 11/30/27

Intervention Study of Drugs in Patients Osteopenia and Osteoporosis

Phase: N/A Priority: Normal
NCT ID: NCT04719572 Org: User:
Start: 03/31/21 End: 01/31/23 Due: 01/31/24

Optical Coherence Tomography Guided Percutaneous Coronary Intervention for Drug-eluting In-stent Restenosis

Phase: N/A Priority: Normal
NCT ID: NCT03809754 Org: User:
Start: 03/01/19 End: 09/01/20 Due: 09/01/21

Treatment of Relapsed and/or Chemotherapy Refractory CD33 Positive Acute Myeloid Leukemia by CART-33

Phase: N/A Priority: Normal
NCT ID: NCT01864902 Org: User:
Start: 04/30/13 End: 04/30/17 Due: 04/30/18

Study on the Model of Smoking Cessation Intervention and Service Ability Improvement

Phase: N/A Priority: Normal
NCT ID: NCT01935505 Org: User:
Start: 10/31/08 End: 12/31/18 Due: 12/31/19

M-ROSE Combined With mNGS in Severe Hospital-acquired Pneumonia

Phase: N/A Priority: Normal
NCT ID: NCT05300776 Org: User:
Start: 05/31/22 End: 12/31/24 Due: 12/31/25

DCHA as Postremission Therapy for AML With t(8;21)

Phase: N/A Priority: Normal
NCT ID: NCT03453255 Org: User:
Start: 01/01/18 End: 12/31/20 Due: 12/31/21

Effects of MSCs Derived Pleiotropic Factors on Wound Healing in Endonasal Surgeries

Phase: N/A Priority: Normal
NCT ID: NCT04536233 Org: User:
Start: 10/10/20 End: 03/30/21 Due: 03/30/22